herpes-zoster

Documents about herpes-zoster

• Shingrix in Patients With Rheumatic Diseases: a Double-blind Placebo-controlled RCT#674777ClinicalTrials.gov
• Zostavax® at Minimum Release Specification Approaching Expiry (V211-044)#859590ClinicalTrials.gov
• A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Adults With Autoimmune Disease (V212-009)#272434ClinicalTrials.gov
• Supplementary Material for: Reactivation of Varicella-Zoster Virus Keratitis after Recombinant Herpes Zoster Vaccination: A Case Report and Literature Review#391590Figshare
• Vigilancia y epidemiología del Herpes Zóster en España, 2014-2024. Red Nacional de Vigilancia Epidemiológica (RENAVE)#437485Repisalud
• Distances From Cricoid Cartilage to the Targets of Stellate Ganglion Block#966106ClinicalTrials.gov
• A Study to Evaluate the Effect of Recombinant Zoster Vaccine on New Diagnosis of Dementia in an Older Adult Population Aged 76 Years or Older in Finland#154730ClinicalTrials.gov
• A Lot-to-Lot Consistency Study to Evaluate Safety, Tolerability, and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Healthy Adults (V212-014)#405214ClinicalTrials.gov
• Dextromethorphan Versus Placebo for Neuropathic Pain#172493ClinicalTrials.gov
• A Study to Test GlaxoSmithKline's (GSK) Herpes Zoster (HZ) Subunit Vaccine's Long-term Immune Response in Previously Vaccinated Kidney Transplant Adults and Then to Test if 2 Additional Doses of the Vaccine Are Safe and Able to Generate an Immune Response#208263ClinicalTrials.gov
• Long-term Immunogenicity of a Live Herpes Zoster Vaccine in Systemic Lupus Erythematosus (SLE) Patients#67674ClinicalTrials.gov
• Safety and Immunogenicity of SYS6017 in Healthy Participants Aged 40 Years or More#451504ClinicalTrials.gov
• Different levels of humoral and cellular immunity to varicella-zoster virus in seropositive healthcare workers#450666S-Space: Seoul National University
• Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases Under Immunomodulators#143636ClinicalTrials.gov
• Code lists for: "Estimating the incidence of acute complications of herpes zoster among immunocompetent adults in England"#268980LSHTM Data Compass
• Mendelian Randomization Research Examining the Effects of Insomnia on Herpes Zoster and Postherpetic Neuralgia.#610505NCBI PubMed Central
• The Immunogenicity and Safety of Zostavax® and Shingrix® in Rheumatoid Arthritis Patients Using Abatacept#290831ClinicalTrials.gov
• Vaccination Education Through Pharmacists and Senior Centers (VEPSC)#307309ClinicalTrials.gov
• A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant#414343ClinicalTrials.gov
• Study to Evaluate Immunogenicity and Safety of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine at 9 and 10 Years After Vaccine Administration and Assessment of Re-vaccination With 2 Additional Doses at 10 Years After Initial Vaccination, in Healthy Subjects Aged 60 Years of Age(YOA) and Older#459958ClinicalTrials.gov
• Profiles of Hesitancy Toward the Herpes Zoster Vaccine Among Older Adults in China: A Latent Profile Analysis.#140500NCBI PubMed Central
• A Study to Test the Safety and Antibody Response of V212 in Healthy Adults (V212-004)(COMPLETED)#290849ClinicalTrials.gov
• A Study to Evaluate Long-term Impact of VARIVAX Among Children and Adolescents (V210-036)(COMPLETED)#980460ClinicalTrials.gov
• Efficacy of valaciclovir in preventing herpes zoster in patients receiving anifrolumab#156363HAL (France)
• The effect of herpes zoster vaccines on incident dementia in England: Protocol for an OpenSAFELY regression discontinuity study#684625Europe PMC
• A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella-Zoster Virus (VZV) Vaccine in Adults With Hematologic Malignancies (HM) Receiving Treatment With Anti-Cluster of Differentiation (CD) 20 Monoclonal Antibodies (V212-013)#432914ClinicalTrials.gov
• Evaluation of the Safety of Varivax® in Pediatric Renal Transplant Recipients#844575ClinicalTrials.gov
• Étiopathogénie de la maladie d'Alzheimer : rôle des Alphaherpesvirus#202420HAL (France)
• Association Between Triglyceride Glucose Index and Postherpetic Neuralgia in Patients with Acute Herpes Zoster: A Retrospective Study#180565Springer Nature OA
• A shared MHC immunogenetic signal connects aging, rheumatoid arthritis, and herpes zoster through chronic high inflammatory burden-compensatory immune tolerance dysregulation#282948bioRxiv / medRxiv
• Ultrasound-Guided Thoracic Paravertebral Block With Steroid and Local Anesthetic for Acute Herpes Zoster: Effects on Pain Control and Prevention of Postherpetic Neuralgia#811871ClinicalTrials.gov
• Estimation of Costs Related to the Management of Herpes Zoster and its Complications in Vietnam: A Medical Chart Review#237344Springer Nature OA
• Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population#908340ClinicalTrials.gov
• Extended data for: Lifetime prevalence of herpes zoster and simplex in electronic health records compared with self-reported lifetime prevalence from population surveys and cohorts in England#618151LSHTM Data Compass
• A Study to Determine if an Investigational Pain Medicine Provides Relief of Chronic Pain After a Shingles Outbreak#852466ClinicalTrials.gov
• Pulsed Radiofrequency Alone Versus Combined With Stellate Ganglion Block for Acute Herpes Zoster-Associated Trigeminal Neuralgia in Patients With Pain Catastrophizing: A Retrospective Cohort Analysis.#988278NCBI PubMed Central
• Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir#995400ClinicalTrials.gov
• A European Delphi Consensus to Support the Diagnosis, Management, and Appropriate Positioning of Topical Treatments for Postherpetic Neuralgia (PHN)#250551Europe PMC
• A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZV#849728ClinicalTrials.gov
• Clinical codelists for: "A comparison of the prevalence of electronic health record diagnoses of herpes zoster and simplex with self-reported prevalence from national population surveys and cohorts in England"#482957LSHTM Data Compass
• Morphological and Metabolic Changes of Dorsal Root Ganglion and Sympathetic Ganglion in Patients With Postherpetic Neuralgia on MRI#847617ClinicalTrials.gov
• Dose-Finding Study of REN-1654 in Patients With Post-Herpetic Neuralgia#873526ClinicalTrials.gov
• Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (HIV-AN) or Postherpetic Neuralgia (PHN)#849783ClinicalTrials.gov
• The efficacy, immunogenicity and safety of a recombinant tetrameric gE-Fc fusion protein vaccine for herpes zoster in adults 40 years of age or older：a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial#4825Europe PMC
• Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I)#895934ClinicalTrials.gov